Studies demonstrate that in hepatocellular carcinoma (HCC), TAMs regulate the activity of serine palmitoyltransferase (SPT) via the kinase NEK2, thereby promoting the biosynthesis of sphingosine-1-phosphate (S1P). Here, AGXT is linked to hepatocellular carcinoma.